Reported 1 day ago
Despite a booming stock market, Novo Nordisk and Healthpeak Properties have seen significant declines in their stock prices, making them potentially undervalued investment opportunities for 2025 and beyond. Novo Nordisk's sales for its obesity treatment are growing, and despite recent stock loss, it shows promising future profits. Healthpeak Properties, a real estate investment trust focused on healthcare facilities, is currently priced attractively after a dividend cut due to a merger. Both companies offer solid dividend yields and have the potential for long-term growth, making them worthwhile additions for investors.
Source: YAHOO